OOIR: Observatory of International Research

Papers

(The H4-Index of Medicinal Research Reviews is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
	193
Design, synthesis, and applications of ring‐functionalized histidines in peptide‐based medicinal chemistry and drug discovery	163
New drug approvals for 2022: Synthesis and clinical applications	137
	130
Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders	127
Galectin‐8 inhibition and functions in immune response and tumor biology	123
Key characters of glycodrugs	120
The role and prospect of lysine‐specific demethylases in cancer chemoresistance	98
Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment	92
Nanotechnology‐based electrochemical biosensors for monitoring breast cancer biomarkers	85
Issue Information	84
Current and emerging approaches to noncompetitive AR inhibition	83
Front Cover Image, Volume 45, Issue 1	73
Metal complexes bearing EGFR‐inhibiting ligands as promising anticancer agents	72
Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel	71
Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer	65
Advances in ameliorating inflammatory diseases and cancers by andrographolide: Pharmacokinetics, pharmacodynamics, and perspective	63
Targeting Histone H3K9 Methyltransferase G9a as a Potential Therapeutic Strategy for Neuropsychiatric Disorders	61
Inside Front Cover Image, Volume 41, Issue 4	60
The ethnomedicinal and functional uses, phytochemical and pharmacology of compounds from Ardisia species: An updated review	60
Mechanism and application of β‐adrenoceptor blockers in soft tissue wound healing	58
α‐Synuclein in Parkinson's Disease: From Bench to Bedside	58
An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators	55
Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases	55
Mitochondrial quality control proteases and their modulation for cancer therapy	48

Emerging roles of nerve‐bone axis in modulating skeletal system	48
Enhancing healthy aging with small molecules: A mitochondrial perspective	46
Current nanocomposite advances for biomedical and environmental application diversity	46
Association predictions of genomics, proteinomics, transcriptomics, microbiome, metabolomics, pathomics, radiomics, drug, symptoms, environment factor, and disease networks: A comprehensive approach	43
Targeting lysosomal quality control as a therapeutic strategy against aging and diseases	42
Issue Information	41
Issue Information	41
Inside Front Cover Image, Volume 44, Issue 5	37
Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis	37
Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds	37
The role of Wnt signaling in skin fibrosis	37
Small molecules targeting different cellular pathologies for the treatment of amyotrophic lateral sclerosis	36